Cargando…
Exosomal miRNA-320a Is Released from hAMSCs and Regulates SIRT4 to Prevent Reactive Oxygen Species Generation in POI
Human amniotic mesenchymal stem cells (hAMSCs) were previously shown to effectively rescue ovarian function in a premature ovarian insufficiency (POI) mouse model. The therapeutic mechanism of hAMSC-derived exosomes (hAMSC-Exos) is not fully understood. In this study, the therapeutic mechanism invol...
Autores principales: | Ding, Chenyue, Qian, Chunfeng, Hou, Shunyu, Lu, Jiafeng, Zou, Qinyan, Li, Hong, Huang, Boxian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7272510/ https://www.ncbi.nlm.nih.gov/pubmed/32506013 http://dx.doi.org/10.1016/j.omtn.2020.05.013 |
Ejemplares similares
-
hAMSC Sheet Promotes Repair of Rabbit Osteochondral Defects
por: Zou, Gang, et al.
Publicado: (2022) -
Enhanced efficiency in isolation and expansion of hAMSCs via dual enzyme digestion and micro-carrier
por: Gohi, Bi Foua Claude Alain, et al.
Publicado: (2020) -
Human amniotic mesenchymal stromal cells (hAMSCs) as potential vehicles for drug delivery in cancer therapy: an in vitro study
por: Bonomi, Arianna, et al.
Publicado: (2015) -
Alteration in Expression of Primordial Germ Cell (PGC) Markers During Induction of Human Amniotic Mesenchymal Stem Cells (hAMSCs)
por: Alifi, Farzane, et al.
Publicado: (2020) -
EGF released from human placental mesenchymal stem cells improves premature ovarian insufficiency via NRF2/HO-1 activation
por: Ding, Chenyue, et al.
Publicado: (2020)